ARCHIVES

Gottlieb questions ODAC’s independence.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

CHOP Evolution Remains Touchy Issues; Contractors Say NCI Plan Too Burdensome

April 22, 1983

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Reinventing NCI: clinical Trials report Calls for Study Section, increased Funding For Cooperative Groups

October 3, 1997

Cervarix Vaccine Approved To Prevent Cervical Cancer

October 30, 2009

NCI Gets Concept Approval for New Communications Network

May 27, 1988

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000